FAEE exerts a protective effect against osteoporosis by regulating the MAPK signalling pathway

Abstract

Context Ferulic acid ethyl ester (FAEE) is abundant in Ligusticum chuanxiong Hort. (Apiaceae) and grains, and possesses diverse biological activities; but the effects of FAEE on osteoporosis has not been reported. Objective This study investigated whether FAEE can attenuate osteoclastogenesis and relieve ovariectomy-induced osteoporosis via attenuating mitogen-activated protein kinase (MAPK). Materials and methods We stimulated RAW 264.7 cells with receptor activator of NF-κB ligand (RANKL) followed by FAEE. The roles of FAEE in osteoclast production and osteogenic resorption of mature osteoclasts were evaluated by tartrate resistant acid phosphatase (TRAP) staining, expression of osteoclast-specific genes, proteins and MAPK. Ovariectomized (OVX) female Sprague-Dawley rats were administered FAEE (20 mg/kg/day) for 12 weeks to explore its potential in vivo , and then histology was undertaken in combination with cytokines analyses. Results FAEE suppressed RANKL-induced osteoclast formation (96 ± 0.88 vs. 15 ± 1.68) by suppressing the expression of osteoclast-specific genes, proteins and MAPK signalling pathway related proteins (p-ERK/ERK, p-JNK/JNK and p-P38/P38) in vitro . In addition, OVX rats exposed to FAEE maintained their normal calcium (Ca) (2.72 ± 0.02 vs. 2.63 ± 0.03, p < 0.05) balance, increased oestradiol levels (498.3 ± 9.43 vs. 398.7 ± 22.06, p < 0.05), simultaneously reduced levels of bone mineral density (BMD) (0.159 ± 0.0016 vs. 0.153 ± 0.0025, p < 0.05) and bone mineral content (BMC) (0.8 ± 0.0158 vs. 0.68 ± 0.0291, p < 0.01). Discussion and conclusions These findings suggested that FAEE could be used to ameliorate osteoporosis by the MAPK signalling pathway, suggesting that FAEE could be a potential therapeutic candidate for osteoporosis.

Exploring the therapeutic potential of isoorientin in the treatment of osteoporosis: a study using network pharmacology and experimental validation

“…In addition, AKT1 can promote osteoblast-osteoclast coupling, and the differentiation of osteoclast precursor cells is diminished in AKT1-deficient mice (Kawamura et al 2007 ; Vandoorne et al 2010 ). During osteoclast formation, c-Fos, a nuclear transcription factor downstream of RANKL, promotes osteoclast formation mainly by activating the downstream factor NFATc1, which acts as the master executor of RANKL-induced osteoclast differentiation/activation and stimulates the maturation of osteoclast precursors (Takayanagi 2007 ; Wang et al 2022 ). In this study, ISO significantly inhibited the phosphorylation of P38, ERK1/2, and JNK in the MAPK signaling pathway, as well as PI3K and AKT1.…”

Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity

“…In this study, we summarize and generalize the signaling pathways involved in OP, which may provide a certain theoretical basis for further elucidation of OP treatment with TCM. According to previous studies, Wnt/β-catenin, BMP-SMAD, MAPK, and RANK/NF-κB/OPG play a key role in OP ( Wang et al, 2022 ; Wei et al, 2022 ) ( Table3 ).…”

Study on mechanism of action of Buyang Huanwu Decoction in treating osteoporosis: Network pharmacological analysis and molecular docking verification

“…In addition, in ammation, oxidative stress and other factors can also accelerate the progression of osteoporosis [4,5] . At present, osteoporosis has been highly valued and widely studied [6] , and its treatment mainly targets osteoblasts and osteoclasts, such as vitamin D, diphosphonate, and selective estrogen receptor modulators (SERMs) [7] . However, due to their poor bioavailability and low permeability, bisphosphonates can induce gastrointestinal reactions, renal impairment, and other side effects [8] .…”